Odonate Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
July 27, 2021 at 08:02 am EDT
Odonate Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 22.054 million compared to USD 33.528 million a year ago. Net loss was USD 22.015 million compared to USD 33.424 million a year ago. Basic loss per share from continuing operations was USD 0.58 compared to USD 1.09 a year ago. For the half year, operating loss was USD 55.872 million compared to USD 64.349 million a year ago. Net loss was USD 55.783 million compared to USD 63.587 million a year ago. Basic loss per share from continuing operations was USD 1.48 compared to USD 2.07 a year ago.